Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

MRNS | Marinus Pharmaceuticals Inc

Index	RUT	P/E	-	EPS (ttm)	-0.15	Insider Own	6.21%	Shs Outstand	49.64M	Perf Week	22.01%
Market Cap	361.86M	Forward P/E	-	EPS next Y	-2.36	Insider Trans	-0.53%	Shs Float	47.47M	Perf Month	2.29%
Income	-29.34M	PEG	-	EPS next Q	-0.66	Inst Own	84.33%	Short Float / Ratio	7.56% / 4.43	Perf Quarter	-29.28%
Sales	25.96M	P/S	13.94	EPS this Y	-408.02%	Inst Trans	1.43%	Short Interest	3.59M	Perf Half Y	15.32%
Book/sh	1.13	P/B	6.31	EPS next Y	9.05%	ROA	-17.83%	Target Price	20.60	Perf Year	4.99%
Cash/sh	3.46	P/C	2.06	EPS next 5Y	80.66%	ROE	-89.11%	52W Range	3.46 - 11.15	Perf YTD	79.65%
Dividend	-	P/FCF	-	EPS past 5Y	30.82%	ROI	-18.50%	52W High	-35.87%	Beta	1.36
Dividend %	-	Quick Ratio	7.50	Sales past 5Y	171.84%	Gross Margin	93.67%	52W Low	106.35%	ATR	0.57
Employees	151	Current Ratio	7.60	Sales Q/Q	239.72%	Oper. Margin	-476.50%	RSI (14)	50.22	Volatility	11.77% 7.67%
Optionable	Yes	Debt/Eq	1.87	EPS Q/Q	42.74%	Profit Margin	-113.01%	Rel Volume	0.78	Prev Close	6.60
Shortable	Yes	LT Debt/Eq	1.77	Earnings	Aug 10 BMO	Payout	-	Avg Volume	810.90K	Price	7.15
Recom	1.27	SMA20	3.89%	SMA50	-11.28%	SMA200	-3.09%	Volume	628,848	Change	8.33%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-11-23	Downgrade	Oppenheimer	Outperform → Perform	$14 → $9
Jan-20-23	Initiated	RBC Capital Mkts	Outperform	$23
Sep-30-20	Initiated	Truist	Buy	$35
Jul-01-20	Reiterated	H.C. Wainwright	Buy	$6 → $9
Jul-01-20	Initiated	Cowen	Outperform
Apr-09-20	Initiated	Craig Hallum	Buy	$4.50
Dec-20-19	Initiated	Oppenheimer	Outperform
Mar-05-19	Resumed	Jefferies	Buy	$3.50 → $10
Feb-27-19	Downgrade	Mizuho	Buy → Neutral	$13 → $5
Feb-06-19	Initiated	Leerink Partners	Outperform	$10
Jul-02-18	Initiated	Cantor Fitzgerald	Overweight	$19
Mar-20-18	Initiated	Mizuho	Buy	$13
Feb-15-18	Initiated	H.C. Wainwright	Buy	$33
Dec-14-17	Initiated	Laidlaw	Buy	$18
Aug-10-16	Reiterated	Jefferies	Buy	$2.50 → $3
Jun-14-16	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Mar-08-16	Reiterated	Stifel	Buy	$23 → $16
Dec-17-15	Initiated	RBC Capital Mkts	Outperform	$14
Nov-17-15	Initiated	Jefferies	Buy	$14
Oct-30-15	Reiterated	Oppenheimer	Outperform	$21 → $17

Show Previous Ratings

Sep-21-23 04:00PM	Marinus Pharmaceuticals to Present at the 2023 Cantor Global Healthcare Conference (Business Wire) -6.18%
Sep-20-23 09:02AM	Marinus Pharmaceuticals (MRNS) Soars 19.9%: Is Further Upside Left in the Stock? (Zacks)
09:01AM	Marinus (MRNS) Up 20% on Financial and Pipeline Updates (Zacks)
Sep-19-23 04:51PM	Marinus Pharmaceuticals extends cash runway, shares surge 16% (Investing.com) +19.88%
08:00AM	Marinus Pharmaceuticals Highlights Advancing Pipeline and Commercial Strategy at Investor and Analyst Event (Business Wire)
04:00PM	Loading…
Sep-12-23 04:00PM	Marinus Pharmaceuticals Announces Speakers for Hybrid Investor & Analyst Event on Tuesday, September 19, 2023 (Business Wire)
Sep-06-23 04:01PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire)
Aug-17-23 04:01PM	Marinus Pharmaceuticals to Host Hybrid Investor & Analyst Event on Tuesday, September 19, 2023 (Business Wire)
Aug-11-23 04:01PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire) -13.56%
09:36AM	Twilio upgraded, Sealed Air downgraded: Wall Street's top analyst calls (The Fly)
Aug-10-23 08:40AM	Marinus Pharmaceuticals (MRNS) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -9.10%
07:34AM	Marinus Pharmaceuticals: Q2 Earnings Snapshot (AP Finance)
07:01AM	Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results (Business Wire)
Jul-31-23 12:03PM	Marinus secures European Commission approval for Ztalmy (American City Business Journals) +5.03%
07:01AM	Marinus Pharmaceuticals Announces European Commission Approval of ZTALMY® (ganaxolone) for the Adjunctive Treatment of Epileptic Seizures Associated with CDKL5 Deficiency Disorder (Business Wire)
07:01AM	Loading…
Jul-27-23 07:01AM	Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2023 Financial Results on August 10, 2023 (Business Wire)
Jul-25-23 03:48PM	Marinus Pharmaceuticals (NASDAQ:MRNS) shareholders have earned a 71% return over the last year (Simply Wall St.)
Jul-13-23 04:30PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire)
Jul-03-23 04:23AM	Strength Seen in Marinus Pharmaceuticals (MRNS): Can Its 5.4% Jump Turn into More Strength? (Zacks)
Jun-21-23 04:01PM	Marinus Pharmaceuticals Announces New Method of Use Patent Granted for IV Ganaxolone by USPTO in Status Epilepticus (Business Wire)
Jun-12-23 07:59AM	Institutional investors are Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) biggest bettors and were rewarded after last week's US$149m market cap gain (Simply Wall St.)
Jun-02-23 04:30PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire)
May-26-23 08:10AM	Marinus Pharmaceuticals Receives Positive CHMP Opinion for ZTALMY® (ganaxolone) for the Adjunctive Treatment of Seizures Associated With CDKL5 Deficiency Disorder (Business Wire)
May-17-23 04:01PM	Marinus Pharmaceuticals Further Strengthens Board of Directors with Appointment of Sarah Noonberg, M.D., Ph.D. (Business Wire)
May-16-23 11:50AM	Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q1 2023 Earnings Call Transcript (Insider Monkey)
06:01AM	Analyst Forecasts For Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Are Surging Higher (Simply Wall St.)
May-11-23 08:35AM	Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:24AM	Marinus Pharmaceuticals: Q1 Earnings Snapshot (AP Finance)
07:01AM	Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results (Business Wire)
May-09-23 04:01PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire)
10:00AM	Loading…
May-04-23 10:00AM	Earnings Preview: Marinus Pharmaceuticals (MRNS) Q1 Earnings Expected to Decline (Zacks)
May-03-23 07:01AM	Marinus Pharmaceuticals to Present at Upcoming Investor Conferences (Business Wire)
Apr-27-23 07:01AM	Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2023 Financial Results on May 11, 2023 (Business Wire)
Apr-18-23 11:03AM	Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) Share Price Matching Investor Opinion (Simply Wall St.)
07:01AM	Marinus Pharmaceuticals Appoints Marvin H. Johnson, Jr. to its Board of Directors (Business Wire)
04:30AM	Marinus Pharmaceuticals (MRNS) Stock Jumps 8.4%: Will It Continue to Soar? (Zacks)
Apr-06-23 04:00PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-22-23 09:01AM	Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone in the Treatment of Lennox-Gastaut Syndrome (Business Wire)
Mar-08-23 12:12PM	Q4 2022 Marinus Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +5.33%
Mar-07-23 05:15PM	Marinus Pharmaceuticals (MRNS) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results (Business Wire)
Mar-06-23 04:01PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire) +6.15%
Feb-15-23 01:00PM	The past five years for Marinus Pharmaceuticals (NASDAQ:MRNS) investors has not been profitable (Simply Wall St.)
10:24AM	Billionaire Steve Cohen Pulls the Trigger on These 2 Strong Buy Stocks (TipRanks)
Feb-13-23 07:15AM	Marinus Pharmaceuticals to Provide Business Update and Report Fourth Quarter 2022 Financial Results on March 7, 2023 (Business Wire)
Feb-10-23 04:01PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-07-23 07:15AM	Marinus Pharmaceuticals to Present at Upcoming Investor Conferences (Business Wire)
Jan-30-23 04:01PM	Marinus Pharmaceuticals Appoints Christine Silverstein to its Board of Directors (Business Wire)
Jan-20-23 02:17PM	Noting Strong Progress On Marinus Pharma's Lead Drug Ganaxolone, Analyst Initiates With 300% Upside (Benzinga) +8.45%
Jan-09-23 04:17PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -6.47%
Jan-05-23 04:01PM	Marinus Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 ZTALMY® Net Product Revenue and Provides Business Update (Business Wire)
Dec-30-22 12:46AM	Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Q3 2022 Earnings Call Transcript (Insider Monkey)
Dec-21-22 07:20AM	Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) top owners are individual investors with 34% stake, while31% is held by institutions (Simply Wall St.) -5.12%
Dec-09-22 04:01PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire)
Nov-30-22 04:01PM	Marinus Pharmaceuticals Announces Presentations and Investor Event at American Epilepsy Society 2022 Annual Meeting (Business Wire)
Nov-18-22 09:00AM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire)
Nov-17-22 01:47PM	Marinus Pharmaceuticals signs collaboration deal worth up to $266M with Chinese biotech firm (American City Business Journals)
09:17AM	Marinus Pharma, Tenacia Biotech Ink Ganaxolone Agreement In China (Benzinga)
07:00AM	Marinus Pharmaceuticals Appoints CEO Scott Braunstein, M.D., as Chairman of the Board (Business Wire)
07:00AM	Marinus Pharmaceuticals Announces Collaboration with Tenacia Biotechnology for Ganaxolone Development and Commercialization in China (Business Wire)
Nov-10-22 12:59PM	Marinus Pharmaceuticals expects to reel in $60M from stock, warrants sale (American City Business Journals)
07:34AM	Marinus Pharmaceuticals Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
Nov-07-22 11:12PM	Marinus Pharmaceuticals Announces Pricing of $60 Million Public Offering (Business Wire)
05:15PM	Marinus Pharmaceuticals (MRNS) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:23PM	Marinus Pharmaceuticals Announces Proposed Public Offering (Business Wire)
04:00PM	Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results (Business Wire)
Nov-04-22 10:55AM	Lab Notes: Marinus secures $32M financing; FDA delays decision on Amicus application (American City Business Journals)
Nov-01-22 10:01AM	Marinus Pharmaceuticals (MRNS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-31-22 07:30AM	Marinus Pharmaceuticals Announces $32.5 Million Revenue Interest Financing Agreement with Sagard Healthcare Partners (Business Wire)
Oct-26-22 09:28AM	What You Need To Know About The Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Analyst Downgrade Today (Simply Wall St.)
09:17AM	Actinium (ATNM) Stock Jumps 8.6%: Will It Continue to Soar? (Zacks)
Oct-25-22 07:30AM	Marinus Pharmaceuticals to Provide Business Update and Report Third Quarter 2022 Financial Results on November 8, 2022 (Business Wire)
Oct-20-22 02:41PM	7 Sizzling Stocks That Are Oblivious to the Manic Market (InvestorPlace)
Oct-14-22 04:30PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire) -7.27%
Oct-11-22 07:30AM	Marinus Pharmaceuticals Announces Multiple Presentations at Upcoming Medical Meetings (Business Wire) -7.28%
Sep-22-22 10:55AM	BARDA Exercises First Contract Option With Marinus Pharma For Its Epilepsy Candidate (Benzinga)
07:30AM	Marinus Pharmaceuticals Announces Exercise of First Contract Option by the Biomedical Advanced Research and Development Authority (BARDA) (Business Wire)
Sep-09-22 04:05PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire)
Sep-08-22 09:03AM	Marinus Pharmaceuticals (NASDAQ:MRNS) shareholders have endured a 59% loss from investing in the stock five years ago (Simply Wall St.)
Sep-07-22 07:30AM	Marinus Pharmaceuticals to Present at Upcoming Investor Conferences (Business Wire)
Aug-29-22 04:01PM	Marinus Pharmaceuticals Announces Closing of Sale of Priority Review Voucher for $110 Million (Business Wire)
Aug-12-22 08:12AM	Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Analysts Just Slashed This Year's Estimates (Simply Wall St.)
08:00AM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire)
Aug-11-22 08:55AM	Marinus Pharmaceuticals (MRNS) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:30AM	Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results (Business Wire)
Aug-05-22 07:29AM	ChemoCentryx (CCXI) Moves 109.2% Higher: Will This Strength Last? (Zacks)
Jul-28-22 07:30AM	Marinus Pharmaceuticals Announces U.S. Commercial Launch of ZTALMY® (ganaxolone) for Seizures Associated With CDKL5 Deficiency Disorder (Business Wire)
Jul-25-22 12:04PM	Here's Why Marinus Pharmaceuticals (NASDAQ:MRNS) Can Manage Its Debt Despite Losing Money (Simply Wall St.)
Jul-15-22 04:05PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire) +8.56%
11:43AM	Marinus (MRNS) to Sell Rare Disease PRV to Novo Nordisk (Zacks)
Jul-14-22 11:07AM	Marinus selling rare pediatric disease priority review voucher for $110M (American City Business Journals) -5.23%
09:11AM	Marinus to sell rare-disease voucher to Novo Nordisk for $110 million (MarketWatch)
07:00AM	Marinus Pharmaceuticals Sells Rare Pediatric Disease Priority Review Voucher for $110 Million (Business Wire)
Jul-13-22 07:30AM	Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2022 Financial Results on August 11, 2022 (Business Wire)
Jun-25-22 10:34AM	What Type Of Shareholders Make Up Marinus Pharmaceuticals, Inc.'s (NASDAQ:MRNS) Share Registry? (Simply Wall St.)
Jun-08-22 07:30AM	Marinus Pharmaceuticals Expands Enrollment Criteria to Support Recruitment in Phase 3 RAISE Trial in Refractory Status Epilepticus (Business Wire)
Jun-03-22 04:01PM	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) (Business Wire) +12.07%
Jun-02-22 10:57AM	2 Strong Buy Penny Stocks That Could Rally All the Way to $30 (Or More) (TipRanks) +19.45%
May-18-22 09:00AM	Marinus Pharmaceuticals to Present at Upcoming Medical and Investor Conferences (Business Wire) -7.80%
May-12-22 05:35PM	Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Tops Revenue Estimates (Zacks) +11.72%

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Braunstein Scott	CHAIRMAN AND CEO	Aug 08	Sale	8.94	30	268	160,762	Aug 08 09:05 PM
Pfanstiel Steven	CFO AND COO	Aug 08	Sale	8.93	14	125	49,324	Aug 08 09:05 PM
Hulihan Joseph	CHIEF MEDICAL OFFICER	Aug 08	Sale	8.93	13	116	47,614	Aug 08 09:05 PM
MANNING MARTHA E	SVP, GEN. COUNSEL & CORP. SEC.	Aug 08	Sale	8.93	11	98	33,025	Aug 08 09:05 PM
Shafer Christina	CHIEF COMMERCIAL OFFICER	Aug 08	Sale	8.93	11	98	40,626	Aug 08 09:05 PM
Braunstein Scott	CHAIRMAN AND CEO	Aug 07	Sale	9.55	6,413	61,244	160,792	Aug 08 09:05 PM
Hulihan Joseph	CHIEF MEDICAL OFFICER	Aug 07	Sale	9.55	2,889	27,590	47,627	Aug 08 09:05 PM
Pfanstiel Steven	CFO AND COO	Aug 07	Sale	9.54	2,790	26,617	49,338	Aug 08 09:05 PM
Shafer Christina	CHIEF COMMERCIAL OFFICER	Aug 07	Sale	9.52	2,385	22,705	40,637	Aug 08 09:05 PM
MANNING MARTHA E	SVP, GEN. COUNSEL & CORP. SEC.	Aug 07	Sale	9.54	2,169	20,692	33,036	Aug 08 09:05 PM
Austin Charles	Director	Feb 06	Sale	6.49	1,073	6,964	5,277	Feb 08 04:36 PM
Fischer Seth H. Z.	Director	Feb 06	Sale	6.54	1,018	6,658	6,026	Feb 08 04:37 PM
Ezickson Elan	Director	Feb 06	Sale	6.56	750	4,920	5,600	Feb 08 04:36 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRNS | Marinus Pharmaceuticals Inc

Upgrade your FINVIZ experience